METTL14 and Parkinson disease: Although direct evidence remains limited, loss of Mettl14 in the substantia nigra increases astrocyte activation, and manganese-induced downregulation of YTHDF2 exacerbates inflammatory responses, suggesting a potential role for m6A regulation in PD pathology [50,98] (Figure 3).